ProfileGDS5678 / 1448756_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 100% 99% 89% 100% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 112.520699
GSM967853U87-EV human glioblastoma xenograft - Control 213.9689100
GSM967854U87-EV human glioblastoma xenograft - Control 312.84599
GSM967855U87-EV human glioblastoma xenograft - Control 47.2829289
GSM967856U87-EV human glioblastoma xenograft - Control 514.357100
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 112.121799
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 212.027899
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 313.103399
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.4199
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 113.01299
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 213.200399
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 313.307499
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 412.098199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 513.492399